ArticleThyroid research2025
Quality of life in pregnant women with subclinical hypothyroidism: clinical management gaps.
Article in Thyroid research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Association of Maternal Thyroid-stimulating Hormone Levels with Psychological Well-being, Sexual Function, and Quality of Life During Pregnancy.Reproductive sciences (Thousand Oaks, Calif.) · 2026Article
- Thyroid function in pregnant Saudi women: A cross-sectional study at a tertiary hospital.Journal of family & community medicineArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSubclinical hypothyroidism (SCH) during pregnancy affects a significant proportion of women, yet its impact on maternal well-being remains insufficiently explored. Current diagnostic and treatment guidelines focus primarily on thyroid-stimulating hormone (TSH) levels, often overlooking the broader implications of SCH on maternal quality of life (QoL). This narrow focus may lead to missed opportunities for interventions that could enhance the overall well-being of this population. In this study, we aimed to assess the impact of SCH on QoL in first-trimester pregnant women and determine whether untreated SCH with TSH levels between 2.5 and 4 µIU/mL compromises maternal well-being. MATERIALS AND
methodsThis is a cross-sectional study conducted on pregnant women during first trimester of pregnancy. Participants were divided into SCH and euthyroid groups based on TSH levels. Data regarding health-related quality of life (HRQoL) was collected using a questionnaire previously described and validated for study population. Data were analysed using descriptive statistics, comparative tests, and multiple linear regression.
resultsAmong 409 pregnant women, those with SCH demonstrated notably lower physical and mental HRQoL compared to those with normal thyroid function. The physical component score was 14.59 ± 3.63 in the SCH group versus 15.96 ± 3.44 in the euthyroid group (p < 0.001), while the mental component score was 20.24 ± 4.24 in the SCH group compared to 22.39 ± 4.55 in the euthyroid group (p < 0.001). This decline affected all areas assessed, including general and mental health, physical function, bodily pain, and social functioning. TSH levels emerged as a significant predictor of overall HRQoL using regression analysis (B coefficient - 1.30,95% CI: -2.08 to -0.52; p = 0.001).
conclusionThis study demonstrates that SCH significantly compromises the HRQoL in pregnant women. The findings underscore the necessity for comprehensive management strategies that not only prioritize the optimization of thyroid function but also address the significant QoL impairments observed in SCH. Given the current lack of treatment recommendations for SCH in pregnant women based on TSH alone, QoL should be incorporated into clinical guidelines to provide more patient-centered care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.